Gliatamin for low mood in adults with type 2 diabetes
Part of Hormones & metabolism, Mental health clinical trials.
This trial tests whether gliatamin (choline alphoscerate) can improve depressive mood in people with type 2 diabetes. You may be eligible if your diabetes is fairly controlled and your depression symptoms are in a mild-to-moderate range.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes (not type 1, not gestational diabetes, not secondary diabetes)
- You are age 50 or older
- Your blood sugar average is not extremely high (HbA1c 10% or lower)
- Your depression score is below 30 but not very low (Beck Depression Inventory between 10 and 29)
- You can safely use contraception if you could become pregnant
- You agree in writing after learning the study, alternatives, and risks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if berberine, a natural compound, can improve both blood sugar and mood in people who have type 2 diabetes and major depression. It aims to understand how berberine works at a molecular level.
This study tests whether a weekly injection of semaglutide (a medication used for weight loss and diabetes) can help reduce symptoms of depression in people who have major depressive disorder and are overweight or obese.
This study tests whether adding magnesium bisglycinate (a mineral supplement) to your current antidepressant medication can help improve depression symptoms. Researchers want to see if this combination works better than antidepressant alone.
This trial tests whether dapagliflozin, a diabetes medication, can help treat major depression. It is for adults who have been depressed for at least 2 months and score high on a depression scale.
This Phase 2 study tests whether adding 5-HTP and creatine can reduce depression symptoms in adults with major depressive disorder. It may help if your current depression treatment hasn’t been fully effective and you meet the safety and medical criteria.
This study tests whether leucine, a common amino acid supplement, can help treat moderate to severe depression in people aged 40–65. You'll have blood tests, an MRI, and a lumbar puncture to measure changes in your brain.
Hear when a new Type2 Diabetes With Depressive Mood trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.